IL-6 activates STAT5 in T cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cytokine

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cyto.2012.07.002PMID 22854263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The composition and signaling of the IL-35 receptor are unconventional

  2012cited by this paper
• STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function*

  2012cited by this paper
• STAT5 is a potent negative regulator of TFH cell differentiation

  2012cited by this paper
• Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report

  2011cited by this paper
• Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

  2011cited by this paper
• STAT-3 inhibitors: state of the art and new horizons for cancer treatment.

  2011cited by this paper
• The value of blocking IL-6 outside of rheumatoid arthritis: current perspective

  2011cited by this paper
• IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation

  2011cited by this paper
• Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity

  2010cited by this paper
• Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis1

  2009cited by this paper
• The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling1

  2009cited by this paper
• Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance

  2008cited by this paper
• Th17 cells in human disease

  2008cited by this paper
• Tocilizumab: the first interleukin-6-receptor inhibitor.

  2008cited by this paper
• Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

  2008cited by this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cited by this paper
• Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

  2008cited by this paper
• Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

  2008cited by this paper
• Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases

  2008cited by this paper
• Actemra poised to launch IL-6 inhibitors

  2008cited by this paper
• New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation.

  2008cited by this paper
• Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

  2008cited by this paper
• Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1

  2007cited by this paper
• Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.

  2007cited by this paper
• Prediction of Graft-Versus-Host Disease in Humans by Donor Gene-Expression Profiling

  2007cited by this paper
• Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

  2007cited by this paper
• Human Resting CD4+ T Cells Are Constitutively Inhibited by TGFβ under Steady-State Conditions12

  2007cited by this paper
• Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells1

  2007cited by this paper
• Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T

  2007cited by this paper
• STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells*

  2007cited by this paper
• Nonredundant roles for Stat5a/b in directly regulating Foxp3.

  2007cited by this paper
• TH-17 cells in the circle of immunity and autoimmunity

  2007cited by this paper
• TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology

  2007cited by this paper
• T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

  2007cited by this paper
• Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

  2006cited by this paper
• Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer

  2006cited by this paper
• STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis.

  2006cited by this paper
• FOXP3: of mice and men.

  2006cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation.

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

  2005cited by this paper
• Expression of biologically active mouse ciliary neutrophic factor (CNTF) and soluble CNTFRalpha in Escherichia coli and characterization of their functional specificities.

  2004cited by this paper
• A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

  2004cited by this paper
• Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• Mini ReviewNew IL-6 (gp130) Family Cytokine Members, CLC/NNT1/BSF3 and IL-27

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

  2003cited by this paper
• Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

  2003cited by this paper
• Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

  2003cited by this paper
• Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells

  2003cited by this paper
• Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited

  2003cited by this paper
• IL-6 signal transduction and its physiological roles: the signal orchestration model.

  2003cited by this paper
• IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms

  2003cited by this paper
• IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

  2002cited by this paper
• IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

  2002cited by this paper
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

  2001cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1.

  2000cited by this paper
• An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction.

  1997cited by this paper
• An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT

  1997cited by this paper
• STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression.

  1997cited by this paper
• CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.

  1997cited by this paper
• Interleukin‐6 and soluble interleukin‐6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast‐like cell formation

  1996cited by this paper
• Transcription Factors Stat3 and Stat5b Are Present in Rat Liver Nuclei Late in an Acute Phase Response and Bind Interleukin-6 Response Elements (*)

  1995cited by this paper
• A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.

  1995cited by this paper
• The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

  1995cited by this paper
• STAT3 and STAT5B Are Targets of Two Different Signal Pathways Activated by Hematopoietin Receptors and Control Transcription via Separate Cytokine Response Elements (*)

  1995cited by this paper
• Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

  1994cited by this paper
• Impaired immune and acute-phase responses in interleukin-6-deficient mice

  1994cited by this paper
• Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

  1993cited by this paper
• Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

  1992cited by this paper
• Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

  1992cited by this paper
• Increased plasma levels of interleukin-6 in sepsis [see comments]

  1989cited by this paper
• Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

  1989cited by this paper
• Increased plasma levels of interleukin-6 in sepsis.

  1989cited by this paper
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

  1989cited by this paper
• Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

  1989cited by this paper
• Preparation of cDNA and the generation of cDNA libraries: overview.

  1987cited by this paper
• Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cells

  1987cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells.

  1987cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper

• DOCK8 and STAT3 cooperate to restrain IgE-inducing T follicular helper cells.

  2026cites this paper
• Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease

  2025cites this paper
• Using mass cytometry to probe the STAT signaling landscape in circulating immune cells in Rheumatoid Arthritis uncovers signaling dysregulation and correlation with disease activity

  2025cites this paper
• Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation

  2025cites this paper
• Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells

  2023cites this paper
• Regulation of Circulating miR-342-3p Alleviates the Radiation-Induced Immune System Injury

  2023cites this paper
• Interleukin-6 stimulates in vitro development of late-stage ovine embryos.

  2023cites this paper
• Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer

  2023cites this paper
• A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates

  2022cites this paper
• A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation

  2022cites this paper
• The STAT family: key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.

  2022cites this paper
• An in vitro alveolar model allows for the rapid assessment of chemical respiratory sensitization with modifiable biomarker endpoints.

  2022cites this paper
• Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL‐6 trans‐signalling

  2022cites this paper
• Stat5b inhibition blocks proliferation and tumorigenicity of glioblastoma stem cells derived from a de novo murine brain cancer model.

  2022cites this paper
• PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer

  2022cites this paper
• COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

  2021cites this paper
• Self-driving armored CAR-T cells overcome suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models.

  2021cites this paper
• Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis

  2021cites this paper
• JAGGED1 Stimulates Cranial Neural Crest Cell Osteoblast Commitment Pathways and Bone Regeneration Independent of Canonical NOTCH Signaling

  2020cites this paper
• CCL26 regulates the proportion of CD4+CD25+FOXP3+ Tregs and the production of inflammatory factors in peripheral blood mononuclear cells following acute ischemic stroke via the STAT5 pathway.

  2020cites this paper
• Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins

  2020cites this paper
• Interleukin 6 trans‐signaling is a critical driver of lung allograft fibrosis

  2020cites this paper
• CCL 26 regulates the proportion of CD 4 + CD 25 + FOXP 3 + Tregs and the production of inflammatory factors in peripheral blood mononuclear cells following acute ischemic stroke via the STAT 5 pathway

  2020cites this paper
• Targeting STATs in neuroinflammation: The road less traveled!

  2019cites this paper
• A comprehensive atlas of immunological differences between humans, mice and non-human primates

  2019cites this paper
• A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity.

  2019cites this paper
• Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication

  2019cites this paper
• Interferon as a Mucosal Adjuvant for an Influenza Vaccine in Pigs

  2019cites this paper
• WITHDRAWN: CREM variant rs17583959 conferred susceptibility to T1D risk in the Tunisian families

  2017cites this paper
• Phosphorylation of STAT proteins by recombinant human IL-6 in immortalized human chondrocyte cell lines, T/C28a2 and C28/I2

  2017cites this paper
• CREM variant rs17583959 conferred susceptibility to T1D risk in the Tunisian families.

  2017cites this paper
• Development of T follicular helper cells and their role in disease and immune system.

  2016cites this paper
• Rôle de l'épithélium et de l'endothélium rénal au cours des glomérulopathies expérimentales. Etude des glomérulonéphrites inflammatoires et des glomérulopathies toxique et hypertensive

  2016cites this paper
• Endocytosis of pro-inflammatory cytokine receptors and its relevance for signal transduction

  2016cites this paper
• Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA

  2016cites this paper
• Transcriptional network profile on synovial fluid T cells in psoriatic arthritis

  2015cites this paper
• High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.

  2015cites this paper
• Protein Expression Require Local Signals to Stabilize FOXP3 Discrete TCR Niche in Human Arthritis and Synovial Regulatory T Cells Occupy a

  2015influential citation
• Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein Expression

  2015influential citation
• Survival Response of Hippocampal Neurons under Low Oxygen Conditions Induced by Hippophae rhamnoides is Associated with JAK/STAT Signaling

  2014cites this paper
• IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.

  2014cites this paper
• Cytokine networking of innate immunity cells: a potential target of therapy.

  2014cites this paper
• Functions and regulation of MUC13 mucin in colon cancer cells

  2014cites this paper
• The Amino Acid Exchange R28E in Ciliary Neurotrophic Factor (CNTF) Abrogates Interleukin-6 Receptor-dependent but Retains CNTF Receptor-dependent Signaling via Glycoprotein 130 (gp130)/Leukemia Inhibitory Factor Receptor (LIFR)*

  2014cites this paper
• Combined Immunodeficiency Evolving into Predominant CD4+ Lymphopenia Caused by Somatic Chimerism in JAK3

  2014cites this paper
• Regulation of IL-6-type cytokine responses by MAPKs.

  2014cites this paper
• The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review

  2013cites this paper
• Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target.

  2013cites this paper